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Free-water transport in fast transport status: A comparison be-
tween CAPD peritonitis and long-term PD.
Background. Ultrafiltration failure (UFF) in continuous am-
bulatory peritoneal dialysis (CAPD) is a transient phenomenon
during acute peritonitis and a permanent complication in long-
term peritoneal dialysis (PD). The high solute transport rates
during acute peritonitis are probably caused by an increased
number of perfused peritoneal capillaries. Long-term PD is as-
sociated with an increased number of peritoneal microvessels,
leading to an enlargement of the anatomic vascular surface area.
This leads to high mass transfer area coefficients (MTAC) and
to UFF. Impaired conductance to glucose, leading to a reduc-
tion in free-water transport, may be a contributing factor to
UFF in long-term PD. We hypothesized that UFF during acute
peritonitis is, in the absence of permanent structural changes,
only caused by an increased vascular surface area, while in long-
term patients it is often the result of an increased surface area in
combination with an impaired conductance to glucose. There-
fore, the peritoneal transport parameters of patients with acute
peritonitis were compared to those in long-term PD patients.
Methods. A standard peritoneal permeability analysis (SPA)
was done in 10 PD patients during the first 48 hours after the
diagnosis of peritonitis. The results were compared to those
obtained in 10 long-term PD patients matched for the MTAC
creatinine. In addition, the results of 8 peritonitis patients were
compared with SPA results of 8 recently started PD patients,
matched for MTAC creatinine.
Results. Peritonitis patients had a deeper maximal dip in D/P
sodium, corrected for diffusion, than long-term patients (0.058
vs. 0.039, P < 0.05). Most parameters of peritoneal fluid trans-
port were not different, except that t50 (i.e., the time to reach
50% of the maximum transcapillary ultrafiltration) was reached
earlier during the dwell in peritonitis than in long-term PD—
128 versus 175 minutes, P < 0.05. This confirmed the difference
in the shape of the intraperitoneal volume versus time curve,
which was blunted in the long-term patients. No differences
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were found for the parameters of solute transport between peri-
tonitis patients and recently started patients.
Conclusion. In contrast to patients with long-term PD, the
osmotic conductance to glucose is unaffected in peritonitis, de-
spite the lower net ultrafiltration caused by high solute trans-
port. This implies that impaired free- water transport in chronic
PD must be regarded as a contributing factor to UFF.
Impaired ultrafiltration with continuous ambulatory
peritoneal dialysis (CAPD) is a transient phenomenon
during acute peritonitis [1] and a permanent complica-
tion in more than 30% of long-term peritoneal dialysis
patients [2, 3]. The higher solute transport rates during
acute peritonitis, compared to the stable situation, lead to
a rapid dissipation of the osmotic gradient caused by aug-
mented absorption of glucose from the peritoneal cavity
[1–6]. The infection-induced hyperpermeability is prob-
ably caused by increased secretion of vasoactive sub-
stances such as prostaglandins and cytokines [7, 8] and
an up-regulation of NO-synthase activity [6, 9–11]. These
mediators are likely to increase the number of perfused
peritoneal capillaries, leading to a functional increment
of the vascular peritoneal surface area. This explains why
the transcapillary ultrafiltration rate (TCUFR) in the first
phase of a dwell during peritonitis is higher than after re-
covery [6]. Transport characteristics usually return to the
baseline level after cure of the peritonitis.
Long-term peritoneal dialysis (PD) is associated with
an increased number of peritoneal micro-vessels [12–
15], causing an enlargement of the anatomic vascular
surface area. Similar to peritonitis, this leads to high
mass transfer area coefficients (MTAC) of low-molecular
weight solutes, and impaired ultrafiltration due to the
fast absorption of glucose from the peritoneal cavity. The
presence of a high or fast transport status is, however, un-
likely to be the only cause of ultrafiltration failure (UFF)
in long-term peritoneal dialysis. Monquil et al [16] an-
alyzed peritoneal solute and fluid kinetics in a selected
group of long-term PD patients with ultrafiltration fail-
ure of unknown cause. The only consistent abnormality
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in these patients was the absence of the sieving of sodium
(i.e., no decrease in the dialysate/plasma Na+ ratio oc-
curred during a 4-hour exchange with a 3.86% glucose
solution). Also, the intraperitoneal volume versus time
curves were blunted, quite dissimilar to previous observa-
tions during acute peritonitis. Instead, these curves were
very similar to those obtained by computer simulations
based on the combination of increased peritoneal glu-
cose transport with a decreased osmotic conductance to
glucose [17]. Impaired free-water transport is one of the
theoretical causes of a decreased osmotic conductance to
glucose. We have argued previously that free-water trans-
port can be assessed by the sieving of sodium, especially
after the correction for sodium diffusion [18]. Using a cut-
off point for diffusion-corrected sodium sieving of 0.045,
we found the combination with a high MTAC creatinine
to be present in 11/20 PD patients with UFF, treated for
more than 4 years (unpublished data).
We therefore hypothesised that UFF during acute peri-
tonitis, when no permanent structural peritoneal changes
are present, is only caused by an increased vascular sur-
face area, while that in long-term patients is often the
result of an increased surface area in combination with
an impaired osmotic conductance to glucose. The aim
of the present case-control study was to compare peri-
toneal transport in patients with acute peritonitis to that
in long-term PD patients matched for the MTAC crea-
tinine. Because a first analysis showed a greater osmotic
conductance to glucose during peritonitis than in long-
term patients, the peritonitis patients were also matched
with recently started PD patients with similar MTACs of
creatinine to elucidate whether the osmotic conductance
to glucose is decreased in long-term PD, or increased dur-
ing peritonitis.
METHODS
A Standard Peritoneal permeability Analysis (SPA)
with a 3.86% glucose solution was performed in 10 pa-
tients within the first 48 hours of acute CAPD peritonitis.
Antibiotic treatment was given according to our proto-
col. The Committee on Medical Ethics of the Academic
Medical Center, Amsterdam, approved the protocol, and
written informed consent was obtained from all patients
after an explanation of the purpose and methods of the
study.
Patients
Peritonitis patients were excluded from the study when
they had clinical signs of UFF prior to the diagnosis or
had been on PD for more than 4 years.
The peritonitis patients had a mean age of 52 years
(range, 25 to 79 years). The duration of CAPD therapy
ranged from 1 to 46 months, mean 17 months. In only 5
peritonitis patients, SPA results within 12 months prior to
the peritonitis episode were available. In this way, these
patients could serve as their own control. For each of
the 10 peritonitis patients a match in a group of stable
long-term patients (arbitrarily defined as duration of PD
of more than 4 years) was selected from our database,
with regard to the MTAC creatinine. The matched long-
term patients had a similar age (47 years, range 28–74),
but were treated with PD for a longer period (90 months,
range 48–144). These patients had no peritonitis at time of
the SPA or in the previous 4 weeks. Because MTAC val-
ues of 18.0 and higher are usually uncommon in recently
started PD patients, only 8 MTAC-matched patients were
available in our database. The median duration of PD in
this group was 3 months (range, 1–4 months), and age was
similar to the peritonitis group. These patients had never
suffered any peritonitis episode.
Procedure
The SPA was performed during a 4-hour dwell period,
as described previously [19], with 3.86% glucose. It was
preceded and followed by a rinsing procedure to avoid
the possible effects of the residual volume before the
test, and to calculate the residual volume after the test.
Dialysate samples were taken before instillation and at
multiple time points during the test (10, 20, 30, 60, 120,
180, and 240 minutes). Blood samples were taken at the
beginning and at the end of the test period. A volume
marker, dextran 70 1 g/L (Hyskon, Medisan Pharma-
ceuticals AB, Uppsala, Sweden) was used to calculate
fluid kinetics. To prevent a possible anaphylactic reaction
to dextran 70, dextran 1 (Promiten, NPBI, Emmercom-
pascuum, The Netherlands) was injected intravenously
before instillation of the test bag [20].
Measurements
Total dextran was determined by means of high-
performance liquid chromatography [21]. Creatinine and
urate were measured by enzymatic methods (Boehringer
Mannheim, Mannheim, Germany). All electrolytes were
determined using ion-selective electrodes. Glucose was
measured by the glucose oxidase-peroxidase method, us-
ing an autoanalyzer (SMA-II; Technicon, Terrytown, NY,
USA).
Calculations
All calculations were performed as previously de-
scribed [19]. Briefly, the changes in intraperitoneal vol-
ume are the result of transcapillary ultrafiltration and
lymphatic absorption. Both parameters were assessed
with the intraperitoneally administered volume marker
dextran 70. Transcapillary ultrafiltration (TCUF) was
calculated from the dilution of the volume marker,
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by subtracting the initial intraperitoneal volume (IPV)
from the theoretical IPV (when both lymphatic absorp-
tion and sampling would not have been present) at any
time point. Because transcapillary ultrafiltration has its
maximum value during the initial phase of a dwell, tran-
scapillary ultrafiltration rate in the first minute (TCUF0-1)
was calculated, using the Lineweaver-Burke plot. That
is, the linear regression between the reciprocal values of
the transcapillary ultrafiltration obtained during the SPA
and the reciprocal of time [22]. This enabled us to cal-
culate the TCUFmax and t50, that is, the time it takes to
reach 50% of the maximal transcapillary ultrafiltration.
The effective lymphatic absorption rate (ELAR) was cal-
culated as the peritoneal dextran clearance. It therefore
included all pathways of uptake into the lymphatic sys-
tem, both subdiaphragmatic and interstitial. The net ul-
trafiltration is the difference between the transcapillary
ultrafiltration and the effective lymphatic absorption. Net
ultrafiltration rate (NUFR) was calculated by dividing the
difference in IPV240min by the dwell time. Peritoneal han-
dling of low-molecular weight solutes was expressed as
mass transfer area coefficients (MTAC). The MTAC rep-
resents the maximal theoretical diffusive clearance of a
solute at t = 0, before transport has actually started. In
this study we used the Waniewski model [23], in which the
solute concentration was expressed per volume of plasma
water [24]:
MTAC(mL/ min) = Vm
t
ln
V1−F10 (P − D10)
V1−Ft (P − Dt )
F is a correction factor (0.5) for convective transport, V10
is the intraperitoneal volume, and D10 the dialysate con-
centration at t = 10 min. Vt and Dt are these parameters at
t = 240 minutes. Vm is the mean intraperitoneal volume.
P is the mean plasma concentration of the solute.
D/P sodium was calculated as the dialysate sodium con-
centration divided by the plasma sodium concentration.
Delta D/P sodium is the difference between the initial
D/P sodium and the lowest D/P sodium (usually after
1–2 hours). A correction for Na+ diffusion from the cir-
culation to the dialysate, known to cause blunting of the
decrease in D/P Na+, was applied as described previously
[18], using the mass transfer area coefficient of urate. This
enabled us to calculate the sodium concentration in the
dialysate due to diffusion. This value was subtracted from
the measured concentration at any time point, resulting
in the actual Na+ sieving.
Statistical analysis
Results are presented as median values and ranges,
because most data were asymmetrically distributed. The
Mann-Whitney-U test was employed to compare the peri-
tonitis patients with the long-term group and with the pa-
tients who were on PD for 4 months or less. In 5 of the
Table 1. Small-solute transport in patients with acute CAPD
peritonitis and 10 long-term PD patients matched for small-solute
transport with MTAC creatinine
Peritonitis patients Long-term PD patients
MTAC mL/min/1.73 m2
Creatinine 14.5 (10.9–23.0) 15.6 (12.2–18.4)
Urate 12.9 (9.2–20.1) 12.7 (9.1–16.4)
Glucose absorption % 65 (45–70) 72 (59–96)
Abbreviations are: CAPD, continuous ambulatory peritoneal dialysis; PD, peri-
toneal dialysis; MTAC, mass transfer area coefficients.
patients, studied during peritonitis, a previous SPA done
within one year was available. The paired sample t test
was used to compare the SPA results of this subgroup.
A P value of less than 0.05 was considered statistically
significant.
RESULTS
All SPAs were performed within 48 hours after the
diagnosis CAPD peritonitis; half of the patients were in-
vestigated within 24 hours. The causative pathogens were
Staphylococcus aureus (1), Staphylococcus epidermidis
(3), Pseudomonas aeruginosa (2), Streptococci (3), and
Corynebacterium xerosis (1). Dialysate cell counts ranged
from 330 to 85,000/mm3, but no correlation was found be-
tween cell count and transport characteristics. The initial
antibiotic treatment was cefalotin intraperitoneally in all
patients. Three of the patients also received gentamicin
intraperitoneally.
Solute transport
The peritoneal solute kinetics are summarized in
Table 1. Although it was not possible to find a complete
match in MTAC creatinine for one peritonitis patient, be-
cause of the high value of 23.0 mL/min, values for mass
transfer area coefficients of creatinine and urate were
similar for both groups. Also, peritoneal glucose absorp-
tion was not different.
Fluid kinetics
The results of the comparison between the peritoni-
tis and long-term patients are given in Table 2 and
Figure 1. Median net ultrafiltration, transcapillary ul-
trafiltration rate, and TCUFmax were similar for both
groups, but TCUF0-1 was higher, and t50 was reached
significantly earlier in the peritonitis patients. Also, peri-
tonitis patients had significantly higher values for the
maximum dip in D/P sodium, compared to the patients
with long-term peritoneal dialysis. The values in the peri-
tonitis patients were within the normal range, suggesting
unaffected osmotic conductance to glucose. This is shown
in Figure 2. The effective lymphatic absorption rate was
not different for both groups.
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Table 2. Fluid kinetics in 10 patients with acute CAPD peritonitis
and 10 long-term patients matched for MTAC creatinine
Peritonitis patients Long-term patients
NUF mL 381 (32–1092) 248 (−111–558)
TCUFR mL/min 3.6 (0.2–6.0) 3.2 (0.8–4.6)
TCUF max mL 1226 (51–2604) 1086 (408–1585)
t50 minutes 128 (12–211) 175 (74–274)a
TCUF0-1 min mL/min 11.2 (2.3–15.7) 6.1 (1.9–14.8)a
ELAR mL/min 1.43 (0.78–2.81) 1.68 (0.43–3.66)
Max delta D/P Na+ 0.058 (0.02–0.12) 0.039 (0.01–0.06)a
Abbreviations are: NUF, net ultrafiltration; TCUFR, transcapillary ultrafil-
tration rate; TCUF max, maximal theoretical intraperitoneal ultrafiltration; t50,
time point where 50% of TCUF max would have been reached; TCUF0-1 min,
TCUFR in the first minute of the dwell; ELAR, effective lymphatic absorption
rate; max delta D/P Na+, maximal dip in dialysate/plasma ratio of sodium after
correction for sodium diffusion from the circulation using the MTAC of urate.
aP < 0.05.
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Fig. 1. Intraperitoneal fluid profiles during the 4-hour dwell. Transcap-
illary ultrafiltration (), effective lymphatic absorption (), and the result
of both, the net ultrafiltration (). In the left panel, the profiles for the
peritonitis patients. In the right panel, those of the long-term peritoneal
dialysis patients. Asterisks mark the values that were significantly dif-
ferent for long-term patients compared to peritonitis patients.
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Fig. 2. D/P sodium corrected for diffusion, during the 4-hour dwell.
The decrease in D/P sodium is the result of dilution of dialysate sodium,
caused by free-water transport. Peritonitis patients showed a deeper dip
(), than those with long-term peritoneal dialysis (). Asterisks mark
the significant difference for long-term patients compared to peritonitis
patients (P < 0.05). D/P, dialysate-to-plasma ratio.
Table 3. Results of previous SPAs in 5 peritonitis patients
Prior to peritonitis During peritonitis
NUF mL 768 (411–860) 523 (127–621)a
TCUFR mL/min 4.40 (2.42–4.62) 3.41 (0.18–412)a
TCUFmax mL 1226 (51–2604) 1086 (51–2439)
T50 minutes 135 (122–354) 89 (12–211)
TCUF0-1 min mL/min 8.1 (5.7–10.9) 10.3 (6.0–15.7)
ELAR mL/min 1.14 (0.75–1.29) 1.22 (0.0–2.58)
Max delta D/P Na+ 0.10 (0.07–0.14) 0.06 (0.04–0.09)
MTACcreat mL/min 8.4 (6.0–12.6) 14.6 (12.3–23.1)a
Abbreviations are: NUF, net ultrafiltration; TCUFR, transcapillary ultrafil-
tration rate; TCUF max, maximal theoretical intraperitoneal ultrafiltration; t50,
time point where 50% of TCUF max would have been reached; TCUF0-1 min,
TCUFR in the first minute of the dwell; ELAR, effective lymphatic absorption
rate; max delta D/P Na+, maximal dip in dialysate/plasma ratio of sodium after
correction for sodium diffusion from the circulation using the MTAC of urate;
MTACcreat, MTAC of creatinine; SPA, standard permeability analysis.
aP < 0.05
Table 4. Comparison of 8 peritonitis patients with 8 patients who
recently started PD treatment matched for MTAC creatinine
Peritonitis patients Patients in first 4
N = 8 months N = 8
NUF mL 381 (32–1092) 379 (−265–911)
TCUFR mL/min 3.6 (1.7–5.97) 3.6 (2.5–5.4)
TCUFmax mL 1365 (461–2604) 1436 (530–2752)
T50 minutes 128 (12–180) 130 (30–345)
TCUF0-1 min mL 11.0 (5.3–15.7) 13.5 (5.1–24.6)
ELAR mL/min 1.7 (0.8–2.8) 1.9 (0.8–2.8)
Max dip D/P 0.065 (0.02–0.12) 0.080 (0.05–0.11)
MTAC creatinine mL/min 14.1 (10.9–19.1) 14.5 (10.9–17.6)
Abbreviations are: NUF, net ultrafiltration; TCUFR, transcapillary ultrafil-
tration rate; TCUF max, maximal theoretical intraperitoneal ultrafiltration; t50,
time point where 50% of TCUF max would have been reached; TCUF0-1 min,
TCUFR in the first minute of the dwell; ELAR, effective lymphatic absorption
rate; max delta D/P Na+, maximal dip in dialysate/plasma ratio of sodium after
correction for sodium diffusion from the circulation using the MTAC of urate;
MTACcreat is MTAC of creatinine.
Comparison with previous SPAs
Results of a previous SPA performed in the preceding
12 months in the absence of peritonitis were available
from 5 of the 10 peritonitis patients. Peritoneal fluid and
solute transport data are compared in Table 3. As ex-
pected, the net UF and TCUFR were lower and solute
transport was higher during peritonitis. However, no sig-
nificant difference was observed in free-water transport
between peritonitis and in the preceding year.
Comparison with patients within the first
4 months of PD treatment
For 8 out of 10 patients a matched control was found
in a group of patients without peritonitis, investigated in
the first 4 months of PD treatment. No differences were
found for the transport parameters between the patients
with peritonitis and the recently started ones, as shown
in Table 4.
DISCUSSION
The comparison made in the present study be-
tween patients with a similar increment of the effective
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peritoneal surface area, either due to acute peritonitis or
to long-term peritoneal dialysis, supports our hypothe-
sis that an impaired conductance to glucose contributes
to UFF in long-term PD. In peritonitis, inflammation-
induced vasodilation and an increased number of per-
fused capillaries leads to an increment of the vascular
surface area, resulting in a rapid dissipation of the osmotic
gradient caused by enhanced glucose absorption. In peri-
tonitis no permanent structural changes are present and
the changes in peritoneal small solute transport are re-
versible. This was supported by the results of experiments
in which peritoneal blood flow was assessed in peritonitis
patients during the infection and after recovery [6]. Con-
sequently, no impairment of the conductance to glucose
is expected.
In long-term PD an anatomical enlargement of the
vascular surface area is the cause of rapid glucose ab-
sorption. Consequently, low ultrafiltration occurs. Sev-
eral studies have shown an increased number of vessels
in the peritoneal membrane of long-term PD patients
with clinical signs of UFF and in patients with peritoneal
sclerosis [12, 15]. Other anatomical changes that were
observed in long-term patients are increased thickness
of the submesothelial collagenous zone of the parietal
peritoneum, and sometimes loss of mesothelial surface
[15, 25]. Although an enlarged vascular surface is by far
the most frequent cause of UFF in long-term PD, other
causes could contribute to the phenomenon [26], such as
a high lymphatic absorption rate or a decreased osmotic
conductance to glucose. The latter is the product of the
peritoneal ultrafiltration coefficient (LpS) and the reflec-
tion coefficient of glucose (r) [17]. A reduced LpS × r
product will lead to a decrease in peritoneal free-water
transport, and therefore to less sodium sieving. Reduced
peritoneal free-water transport, estimated either by the
sieving of sodium or by the difference in net ultrafiltration
obtained with a 3.86% and a 1.36% glucose solution [27],
is present in long-term patients [16, 26] and in patients
with peritoneal sclerosis [28]. LpS is the product of liquid
permeability (Lp) and the peritoneal surface area (S). As
S is increased in long-term PD, a marked reduction of
Lp would have to be present to explain the decreased
osmotic conductance to glucose by a decreased LpS. Lp
is unlikely to be low, as transport rates of low-molecular
weight solutes are high in long-term PD with UFF [29].
It is therefore more likely that a reduced r explains the
decreased free-water transport. r is, to a large extent,
dependent on the function of peritoneal aquaporins, as
these water channels are permeable to water and not to
glucose. As they are also not permeable to sodium, the
reduced peritoneal free-water transport is likely to be
caused by an impaired function of peritoneal aquaporin-
1. This is unlikely to be caused by a reduced number of
water channels, because the expression of aquaporin-1
has been found normal in UFF [30]. Thus, the decreased
water transport can most likely be attributed to a func-
tional impairment of the water channels, although the
nature of the defect is yet unrevealed.
Based on our previous observations that a reduced
sodium sieving was especially present in long-term PD
patients, we assumed that impaired aquaporin-1 function
would result from continuous exposure to bioincompati-
ble PD solutions. If so, it should not be present in acute
peritonitis. Therefore, we performed the present study, in
which patients with acute peritonitis were matched with
stable long-term patients on the basis of their MTAC cre-
atinine, reflecting the vascular surface area. The criteria
for the analysis of the free-water transport consisted
of the sieving of sodium after correction for diffusion
and the profile of the intraperitoneal volume during the
4-hour dwell using a 3.86% glucose dialysate. Because
net ultrafiltration and lymphatic absorption were not dif-
ferent in both groups, the two curves should have been
identical, if the large vascular surface area would have
been the only causative factor of impaired net ultra-
filtration in long-term peritoneal dialysis. The shape of
the transcapillary ultrafiltration versus time curves, how-
ever, was markedly different. In peritonitis, a sharp rise
in intraperitoneal volume was found, followed by a de-
crease. The initial rise in the long-term patients was much
less steep. The resulting flattened ultrafiltration profile
points to a reduced osmotic effect of the hyperosmo-
lar glucose solution. This hypothesis is also supported
by the data shown in Figure 2, where the difference in
the dip of D/P sodium is obvious. Both curves show a
remarkable resemblance with the computer models of
Rippe et al, in which a reduced osmotic conductance to
glucose was simulated [17, 31]. The t50, which was sig-
nificantly earlier in peritonitis than in MTAC-matched
long-term patients, also points to a defect in free-water
transport in chronic PD. The assumption that indeed os-
motic conductance to glucose is impaired in long-term
PD, and not augmented in peritonitis, is supported by the
results of the comparison of 8 patients during peritonitis
with the MTAC-matched, recently started controls. This
group showed similar transport parameters compared to
the peritonitis patients, implying that free-water trans-
port in peritonitis is unaffected, whereas it is significantly
lower in the long-term patients. In addition, the results
of the 5 patients who were investigated within one year
prior to the peritonitis episode also suggest that osmotic
conductance to glucose was unchanged during peritoni-
tis. This indicates that the impaired osmotic conductance
is likely to be the result of chronic exposure to PD. In the
present study, no control SPA was performed after the
peritonitis episode, in order to confirm that the changes
in peritoneal transport were reversible. However, previ-
ous studies on this subject showed complete recovery of
transport parameters after recovery from peritonitis [8].
Because no long-term data on peritoneal water transport
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are available, longitudinal studies in large patient groups
on the changes in the osmotic conductance to glucose are
required.
In contrast with our findings, Combet et al [10] found
impaired sodium sieving in rats with acute peritonitis. The
difference is most likely explained by the correction for
sodium diffusion made in the present study. High diffu-
sion rates during acute peritonitis otherwise would have
caused blunting of the D/P sodium ratio due to rapid
transport of sodium from the circulation to the dialysate,
also in our patients with peritonitis.
CONCLUSION
The peritoneal free water transport is within the normal
range during acute peritonitis, whereas it is a contribut-
ing factor to UFF in long-term PD. The reason for this
impaired osmotic conductance to glucose is probably the
long-term treatment with bioincompatible dialysis fluids,
but further studies are required to determine the precise
pathogenesis.
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